Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | GTCpFE |
Synonyms | |
Therapy Description |
GTCpFE is a prodrug of acetylsalicylic acid (aspirin), which inhibits the activity of NF-kappa B, potentially leading to decreased tumor cell viability and a reduction in cancer stem cells (PMID: 26530254, PMID: 28190074). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GTCpFE | GTCpFE is a prodrug of acetylsalicylic acid (aspirin), which inhibits the activity of NF-kappa B, potentially leading to decreased tumor cell viability and a reduction in cancer stem cells (PMID: 26530254, PMID: 28190074). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|